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AT A GLANCE COMMENTARY 
Scientific Knowledge on the Subject 
It is unknown what are the functional ventilatory consequences of carotid body morphological and molecular 
changes observed in aged animals, as well as the ventilatory effects of dopamine and adenosine in the old. 
What This Study Adds to the Field 
Carotid body peripheral control of ventilation is not impaired in aging. The preservation of the inhibitory and 
excitatory effects on ventilation caused by exogenous dopamine and adenosine, respectively, should be taken in 
account in the therapeutic use in the old of these amines and their agonists and antagonists.  
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Abstract 
Rationale: Carotid body (CB) is the main arterial chemoreceptor with a low threshold to hypoxia. CB activity is 
augmented by A2-adenosine receptors stimulation and attenuated by D2-dopamine receptors. The effect of aging 
on the ventilatory responses, mediated by the CB, to hypoxia, ischemia and to adenosine and dopamine 
administration is almost unknown. 
Objectives: To investigate in old rats the ventilatory responses to ischemia and to adenosine, dopamine and 
their antagonists, as well as the effect of hypoxia on adenosine 3’,5’-cyclic monophosphate (cAMP) 
accumulation in the CB.  
Methods: In vivo experiments were performed on young and aged rats, anaesthetized with pentobarbitone and 
breathing spontaneously. CB ischemia was induced by bilateral common carotid occlusions. cAMP content was 
measured in CB incubated with different oxygen concentrations.  
Measurements and Main Results: Hyperoxia caused a decrease in cAMP in the CB at all ages, but no 
differences were found between normoxia and hypoxia, as well as between young and old animals.  Endogenous 
dopaminergic inhibitory tonus is slightly reduced, however both the decrease in ventilation caused by exogenous 
dopamine and the increase mediated by A2A-adenosine receptors, is not impaired in aged animals. The 
bradycardia induced by adenosine is attenuated in old rats. 
Conclusions: CB peripheral control of ventilation is preserved in ageing. Concerns to the clinical interest of 
adenosine to revert supraventricular tachycardia in aged people and to the use of dopamine in critical care 
situations were also advanced.  
Word count for the Abstract: 233 
Keywords: Aging; Peripheral Chemoreceptors; Ventilation; Domperidone; 
cAMP, Adenosine A2A receptors 
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INTRODUCTION  
At the periphery, mammalian carotid bodies (CBs) are the main chemoreceptor organs that control ventilation 
sensing O2 (PO2), CO2 (PCO2) and pH in arterial blood and initiating compensatory reflex responses via 
increased carotid sinus nerve (CSN) afferent activity, resulting in corrective changes in ventilation. CB glomus 
cells synaptically connected between them and with the afferent nerve terminals, depolarize in response to PO2, 
PCO2 and pH, releasing excitatory (acetylcholine, adenosine and ATP) or inhibitory (dopamine) transmitters 
(Iturriaga & Alcayaga, 2004). 
It is known that ageing causes marked changes in the morphology of the CBs , reduces  catecholamine release 
and CSN output in response to hypoxia in isolated CBs of rats (Conde et al., 2006). In contrast, in healthy 
humans it has been suggested that peripheral chemoreceptor activity is not impaired by ageing (Smith et al., 
2001). Functional experiments in vivo models to deal with the gap between in vitro isolated preparations of the 
CBs and humans are missing. 
Occlusions of the common carotid artery during short periods (s) have been used as a functional model of 
accessing peripheral chemoreceptor responses (Alcayaga et al., 1986). The effects of ageing on the 
cardiorespiratory reflexes induced by carotid ischemia have never been studied.  
Dopamine has inhibitory effects on ventilation at rest (Zapata & Zuazo, 1980) and in the presence of hypoxic 
exposure (Nishino & Lahiri, 1981) mediated by D2-receptors localized at the CB (Gonzalez et al., 1994). No data 
are available concerning the effects of ageing on D2-receptors at the CB.  
A2-adenosine receptors at the CB are involved in the stimulation of breathing in basal conditions (McQueen & 
Ribeiro, 1986;Monteiro & Ribeiro, 1987) and in response to hypoxia (Conde & Monteiro, 2004).  
In the present work, CB function was assessed measuring the ventilatory responses induced by acute CB 
ischemia and exogenous administrations of adenosine and dopamine and their receptor antagonists. Changes in 
cAMP content, in response to oxygen concentrations in aged rats, were also investigated as a cellular indicator of 
CB function. cAMP has been postulated to modulate the response of the CB to hypoxia, and is the common 
pathway of the activation of both dopamine and adenosine receptors at the CB (Batuca et al., 2003). The effects 
of ageing on cAMP production at the CB have never been addressed. An additional reason to test this hypothesis 
is that age-related alterations in the adenylate cyclase/cAMP system have been documented in other structures. 
For example, impairment of the activity of the catalytic subunit of adenylate cyclase was observed in rats (Kilts 
et al., 2002), and in the heart of > 60 year old humans (Brodde et al., 1995). However, on the contrary, it has 
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been described that the maximal ability of forskolin to increase cAMP in the adrenal medulla and liver is 
enhanced in 24 month old rats (Tumer et al., 1996). 
The results obtained in the present work will also contribute to investigate whether changes in the magnitude of 
the cardiorespiratory responses induced by dopamine and adenosine administration for clinical purposes (shock 
and supraventricular tachycardia, respectively) would be expected in elder people. 
 METHODS 
Animals and House Conditions 
Experiments were performed on male Wistar rats aged 3, 12 and 24 months. The animals were housed in the 
vivarium of the university, in an air-conditioned room at 21±1°C, 55±10% humity, with a 12:12 h light/dark 
cycle (with lights on at 08:00 and off at 20:00), and with food and water available ad libitum. All surgical 
procedures and experimental protocols were handled in accordance with the EU guidelines for use of 
experimental animals (86/609/EEC), with care to minimize the number of animals used and their suffering. The 
investigators own FELASA level C certification and euthanasia of the rats was achieved by i.v. injection of a 
lethal dose of pentobarbital sodium (180 mg.Kg-1 iv).  
In vivo Experiments 
A detailed description of these methods was previously published (Monteiro & Ribeiro, 1987;Monteiro & 
Ribeiro, 1989) and can be found in the online supplement.  Briefly, respiratory frequency (fR), tidal volume (VT), 
blood pressure (BP) and heart rate (HR) were continuously recorded in anesthetized and vagotomized rats 
breathing spontaneously and submitted to bilateral occlusions (5-15 s) of the common carotid artery, or to drugs 
administered into de common carotid artery or femoral vein.  Control experiments to distinguish central and 
peripheral mediated effects were performed in animals after bilateral denervation of the CBs by cutting the CSN.  
Experimental protocols with cAMP 
Immediately after surgical removal from the carotid bifurcation of anaesthetized rats the CBs were submitted to 
similar experimental conditions published elsewhere (Batuca et al., 2003) and described in the online 
supplement. Essentially, CBs were incubated in solutions, containing 500µM of isobutylmethylxanthine (IBMX) 
equilibrated with 95 %O2/5 %CO2 (hyperoxia), 20 %O2/5 %CO2/75 %N2 (normoxia), 10 %O2/5 %CO2/85 %N2 
(mild hypoxia) or 5 %O2/5 %CO2/90 %N2 (moderately intense hypoxia), during 30 min. cAMP was assayed 
using an EIA commercial kit (GE Healthcare Bio-Sciences AB, Sweden).  
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Statistics  
In in vivo experiments, each animal served as its own control. To facilitate comparisons between young and old 
animals, cardiorespiratory data are expressed as percent change. Data are expressed as mean ± S.E.M. and 
statistical significance was evaluated by using the Student’s paired and unpaired t-test for in vivo experiments 
and one-way analysis of variance for in vitro experiments, with p values < 0.05 taken as significant. Models for 
analysis were developed using GraphPad Prism software (Version 4.03). 
Drugs  
All drugs were prepared on the day of each experiment. Doses of all drugs were calculated on the basis of salt 
weight. Dopamine, adenosine and domperidone were prepared in saline (0.9% NaCl). Stock solutions (5mM) of 
SCH 58261 was prepared in dimethylsulfoxide (DMSO) and stored at –20ºC until use. Stock solution was 
further diluted with saline prior to each experiment. The highest concentration of the vehicle in venous perfusion 
was 0.4 mM or 0.01%.  
Adenosine (Adenocor) was obtained from Sanofi-synthelabo (Portugal). 
Dimethyl-sulfoxide (DMSO) was obtained from J.T.Baker (Holland). 
Domperidone was obtained from Sigma-RBI Chemical (Potugal/USA). 
Dopamine (Medopa) was obtained from Medinfar (Portugal). 
Heparine sodium was obtained from B. Braun Medical (Portugal). 
Isobutylmethylxanthine (IBMX) was obtained from Sigma-Aldrich (Portugal) 
SCH 58261 (7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazole-[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidine) was 
obtained from Sigma-RBI Chemical (Potugal/USA). 
Sodium pentobarbitone (Eutasil) was obtained from Sanofi-Veterinária (Miraflores, Algés,Portugal). 
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 RESULTS 
Age-Related Evolution of the Body Weight  
Figure 1 shows the age-related increase in body size in rats between 3 and 24 months. Statistical significant 
differences were found between body weight in 3 months old animals (431.0±7.4 g, n=30) and older ages.  No 
differences were observed between weight in 12 (618.1±16.9g) and 24 (641.0±11.3 g) months old animals.  
Effects of Ageing in Resting Ventilatory and Cardiovascular Parameters  
The effects of ageing on resting cardioventilatory parameters in anaesthetised rats are illustrated in Figure 2. The 
basal values of fR were maintained constant throughout ageing (49.8±1.2, 52.26±1.5 and 46.6±1.5 breaths.min
-1, 
respectively in 3, 12 and 24 months old rats). Whereas significant decreases (p<0.01) in VT (8.8±0.3, 6.0±0.3 and 
7.0±0.4 mL.Kg-1, respectively in 3, 12 and 24 months old rats) and VE (442.5±24.2, 316.4±12.4 and 322.9±18.8 
ml.min-1.Kg-1, respectively in 3, 12 and 24 months old rats), decreased significantly (p<0.01) after were evident 
in 12 months and older animals (Figure 2A, 2B and 2C). 
Basal values of HR and BP at 12 months old were 322.2±9.2 beats.min-1 and 92.6±5.4 mmHg, respectively. 
These values were lower than those observed in 3 months old animals but not statistically different than those 
recorded in older animals (Figure 2D and 2E)  
Effect of Ageing on Ventilatory Responses Induced by Common Carotid Occlusions 
Bilateral CCO during 5, 10 and 15 s induced a time-dependent excitatory effect on ventilation (Figure 3) that is 
totally abolished by carotid sinus nerve section. This excitatory effect on ventilation caused by carotid ischemic 
stimuli was preserved in old rats (Figure 3). The transient increases in BP observed in young and old animals 
during CCO (Figure 3A and 3B), were similar in both groups. No apparent changes in HR were detected during 
CCO in the 3 groups of animals. 
Cardioventilatory Responses to Dopamine 
Dose-response curves for the effects of i.c. bolus injections of dopamine (3-100 nmol) on cardioventilatory 
parameters in anestethized and vagotomized rats are showed in Figure 4. The inhibitor effect of dopamine on 
ventilation, and its slight increases in HR and BP were dose-dependent and of the same magnitude in both young 
adults and aged rats. As previously shown by others (Zapata & Zuazo, 1980), bilateral section of the CSN 
completely abolished the inhibitory effect caused by dopamine on fR, VT and VE but did not change the increase 
in BP (not shown). The effect of dopamine on cardioventilatory parameters was also tested in the presence of 
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domperidone, a dopamine D2–receptor selective antagonist that does not cross the blood-brain barrier. 
Domperidone (0.01-0.5 mg.Kg-1, min-1/2.35-137.5 mol. Kg-1, min-1; i.v. infusion) almost totally abolished the 
depression on VE induced by dopamine (Figure 5). The antagonism is dose-dependent, and of the same 
magnitude in 3, 12 and 24 month old rats (Figure 5A, 5B and 5C).  In contrast, domperidone (0.01-0.5 mg.Kg-
1.min-1, i.v.) did not modify the effects of dopamine on BP and HR either in young or aged animals (Figure 5D 
and 5E). The effect of domperidone infusion (0.01-0.1 mg.Kg-1.min-1) by itself in the absence of exogenous 
dopamine, on VE in 3 and 24 months old rats is illustrated in Figure 6. Domperidone alone caused statistically 
significant increases in basal VE in both young and aged animals in a dose-dependent manner. Although the 
excitatory effect of this D2-dopamine antagonist on ventilation is significantly (p<0.01) attenuated in aged 
animals (Figure 6A).  The maximal excitatory effect (66.88.1 breaths.Kg-1.min-1) was achieved with 0.1 mg.Kg-
1. min-1 in young animals. The higher dose (0.5 mg.Kg-1.min-1) caused a less pronounced (44.312.9 %) effect on 
ventilation. Domperidone (0.01 and 0.1 mg.Kg-1.min-1) by itself did not cause apparent modifications in both HR 
and BP.  
Cardioventilatory Responses to Adenosine 
The results obtained in the experiments performed to investigate whether the excitatory effect of adenosine on 
ventilation was modified by age are shown in Figure 7. Dose-response curves for the effects of i.c. bolus 
injections of adenosine (3-100nmol) on fR, VT, VE, HR and BP were obtained in 3 months and 24 months old 
rats. As expected, adenosine by itself caused excitatory effects on VE due to increases in both fR and VT (Figure 
7A, 7B and 7C). Adenosine 100 nmol, increased VE by 60.9±2.9 and 55.1±3.7 %, respectively in 3 and 24 
months old rats. The responses in fR, VT and VE to exogenously administered adenosine were remarkably similar 
in 3 and in 24 months old rats (Figure 7A, 7B and 7C). As previously shown by others (Monteiro & Ribeiro, 
1987), respiratory effects of adenosine were abolished by CSN section (not shown).  An immediate decrease in 
the HR and BP that remained in animals after bilateral section of the CSN was also induced by exogenous 
adenosine. The hypotensive and bradycardic effect of adenosine (100nmol) were clearly attenuated in 24 month 
old rats (Figure 7D and 7E). 
In a group of experiments, i.c. bolus injections of adenosine were performed during i.v. infusion of an A2A-
adenosine receptor antagonist, SCH 58261. The effect of adenosine 100 nmol on VE was fully abolished by SCH 
58261, 20 ng.Kg-1.min-1, in both young and old animals (Figure 8A and 8B). Figure 8 also depicts that adenosine 
A2A-receptors blockade (SCH 58261; 2-20 ng.Kg
-1.min-1 i.v.) did not prevent the decrease in HR and BP evoked 
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by adenosine in both young and old animals. In contrast, a small potentiating of the bradycardic effect of 
adenosine by SCH 58261 was observed  in old animals (Figure 8D).   
SCH58261 alone  in the dose of 2 ng.Kg-1.min-1 i.v., significantly (p>0.01) increased VE (18.5±0.5 and 16.4±0.8 
%, respectively in 3 and 24 months old rats), whereas the dose of 20 ng.Kg-1.min-1 i.v. did not cause  by itself, 
appreciable changes in VE in both  3 and 24 months old rats (Figure 9). 
Administration of the adenosine A2A-receptor antagonist SCH 58261 alone had no effect on HR or BP (Figure 
9). 
Effects of Age on cAMP Levels in CBs in Response to Different Oxygen Concentrations 
The cAMP levels in CBs isolated from 3, 12, 18 and 24 months old rats, incubated in normoxic solutions 
(20%O2) are shown in Figure 10A. No differences were found between cAMP levels in CBs of young and old 
rats expressed by CB or corrected by the CB weight at different ages (Figure 10A). The weights of the CBs (g) 
slightly changes throughout aging and were: 49  7 (3 months), 46  8 (12 months), 75  12 (18 months) and 
70  10 (24 months). 
Figure 10B shows the effect of aging on cAMP production induced by different oxygen concentrations applied 
to the CBs. PO2 of around 677 mmHg (incubating solutions equilibrated with 95 %O2 / 5% CO2) yields cAMP 
levels significantly lower than those found when the incubating PO2 is close to physiological or normoxic 
( 142 mmHg; incubating solutions equilibrated with 20 %O2 / 5 %CO2). In the CB, the normoxic level of 
cAMP was maintained at lower PO2 of  71 (10%O2) and 35 mmHg (5% O2). This pattern and the amount of 
cAMP production by the carotid bodies did not change with aging. 
DISCUSSION 
This functional approach of carotid body chemoreceptors activity that included ventilatory responses to 
ischemia, pharmacological manipulation of two important carotid body neuromediators and intracellular cAMP 
accumulation induced by changes in O2, showed that peripheral control of ventilation is not apparently impaired 
in ageing.  
The ageing process is characterized by a decline in several physiological functions, with the result of a reduction 
in the ability to maintain homeostasis (Troen, 2003). However, there is an increasingly body of evidence that 
several physiological functions are well preserved in ageing. Namely, several studies in humans have examined 
the age-related changes in ventilatory response to hypoxia and found a maintained ventilatory response 
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throughout aging, suggesting no alteration in peripheral quimoreception in the old humans (Pokorski et al., 
2004;Smith et al., 2001;Vovk et al., 2004). 
The present work contributes indirectly to know the effect of ageing in the oxygen-sensing mechanisms, and was 
focused in the peripheral control of ventilation mediated by the CB. 
It was previously described that respiratory frequency decreases with increasing size of the animals and declined 
in a linear fashion with increasing age in rat (Soulage et al., 2004). Healthy elderly subjects at rest breathe with a 
VE identical to that of younger subjects, but with smaller VT and higher fR (Janssens et al., 1999). In the 
experimental conditions of our model, a significant increase in rat weight was found after 12 months old, but the 
basal values of fR were maintained constant throughout ageing. Since the animals were vagotomized and under 
the influence of sodium pentobarbitone anaesthesia showed lower values of fR (46.6±1.5 breaths.min
-1) which 
could explain the absence of bradypnea found by others in old rats where basal values of fR were 104.7±3.4 
breaths.min-1. The absence of changes in fR when the input of the major pulmonary stretch receptors is abolished 
by vagotomy and CNS activity depressed by the barbiturate, suggest that changes in fR in the elderly could not 
be attributed to an impairment of the CB peripheral drive. 
Wistar rats exhibited, in the present conditions, a diminution of tidal volume with ageing. Although some 
authors did not find tidal volume to decrease with advancing age (Soulage et al., 2004), an age-related decrease 
were commonly observed in rats (Nagase et al., 1994) and humans (Janssens et al., 1999) with advancing age, 
and have been linked to alterations of the mechanical properties of lung and thorax (Chan & Welsh, 1998). 
The cardiovascular effects associated with ageing are: a striking attenuation in the cardiac frequency in humans 
(Kronenberg & Drage, 1973); no significant effect of age on resting HR of rats (Gordon, 2008) and increase in 
blood pressure in both rats (Di et al., 2009) and humans (Fleg et al., 1995). In the present work mean arterial 
blood pressure was lower in 24 months old rats than in young adults. This finding could be attributed to the 
predominant effect of anaesthetic mediated central cardiovascular depression (Schwenke & Cragg, 2004) over 
the arterial dysfunction in ageing. It is known that the risk of cardiovascular depression induced by barbiturates 
is higher in the elderly (Schwenke & Cragg, 2004) and compatible with the lower values for BP found in the 
present work, despite lower doses of anaesthetic were needed to abolish sensitivity in old animals.  
There is a consensual body of evidence about the changes in the morphology of the CB throughout ageing: 
increase in extracellular matrix, reduction in number and volume of type I cells, and in the volume and density of 
mitochondria compared with young CB (Conde et al., 2006;Pokorski et al., 2004;Hurst et al., 1985). These 
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morphological findings do not apparently agree with the absence of functional impairment, but the increases in 
the number of type II stem cells could contribute to the maintenance of CB function (Hurst et al., 
1985;Porzionato et al., 2005). The present work supports previous findings in humans - absence of alterations in 
the peripheral control of ventilatory responses to hypoxia (Pokorski et al., 2004;Vovk et al., 2004), providing 
evidence that structural and neurochemical changes caused by ageing at the carotid body are further 
compensated. The finding that changes in cAMP content at the CB in response to O2 concentrations did not 
change with ageing, suggests that the compensatory mechanism could occur within the CB as a whole. These 
results contrast with the reduction in carotid sinus nerve discharges in response to hypoxia observed in old rats 
(Conde et al., 2006). It is known that the glossopharyngeal nerve has, in addition to carotid sinus nerve afferent 
fibres, a parallel autonomic parasympathetic efferent pathway, sensitive to hypoxia that is the source of CB 
inhibition (Campanucci et al., 2006). We can speculate that the reduction in CSN discharges found in old 
animals) (Conde et al., 2006) could be mainly due to an impairment of the efferent fibre activity without changes 
in chemosensory excitatory afferent pathway. Similarly, it was shown in humans that ageing impairs the 
autonomic responses to pain but does not modify nociceptive perception (Hajduczok et al., 1991).  
Hyperventilation induced by bilateral brief (<15s) occlusions of the common carotid arteries are abolished by 
carotid sinus nerve section (Monteiro & Ribeiro, 1989), constituting an alternative model to hypoxia in order to 
study CB chemosensory activation in vivo. In the present work the cardiorespiratory reflexes induced by carotid 
ischemia were similar in young and old rats. The effects of ageing on the ventilatory reflexes induced by carotid 
ischemia were here shown for the first time. Carotid sinus baroreflex function throughout ageing has never been 
studied in this model but maintenance of carotid baroreflex function in advanced aged rats was previously 
described in anaesthetized Fisher rats (Wei et al., 1986). In humans, there is no difference in carotid body 
baroreflexes throughout ageing   (Fiocchi et al., 1985;Shi et al., 1996).   
Other aspect to consider in our discussion relates to the age-dependent variations in cAMP levels and responses 
to hypoxia. Ageing did not cause appreciable changes in cAMP levels at the CB. The normoxic cAMP levels are 
not different at the four ages studied, and the pattern of cAMP production in response to different O2 
concentrations remained almost unchanged in old animals. Expressed by unit weight, the levels of cAMP found 
for the rat CB in the present study are nearly identical to the values reported in the rabbit CB (Chen et al., 
1997;Perez-Garcia et al., 1990). At all ages, cAMP levels were maximal in normoxic conditions. In comparison 
to normoxia, hyperoxia caused a decrease in cAMP in the CB at all ages. Adenosine effects via A2 receptors, 
which are known to be expressed in the CB (Gauda, 2002), can represent one of the mechanisms maintaining 
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high cAMP levels in hypoxia. It is worth noting that the release of adenosine in the CB is maximal at mild levels 
of hypoxia (10 %O2), decreasing with higher intensities of hypoxic stimulation and that the most intense hypoxia 
used in this study does not increase the release of adenosine in the SCG or CA (Conde & Monteiro, 2004). Of 
course adenosine is not the only modulator of cAMP levels in the CB, as it is well known that hypoxia also 
increases the release of many other neurotransmitters, particularly dopamine (Vicario et al., 2000). It is also 
known that the CB expresses high levels of D2 dopamine receptors (Gauda, 2002) which are negatively coupled 
to adenylate cyclase (Kebabian & Calne, 1979). In fact, it would appear  that the much higher rate of dopamine 
release in the rat vs. the rabbit CB in hypoxia (Vicario et al., 2000) can explain the inability of hypoxia to 
increase the cAMP levels in the rat CB above those found in normoxia, as has previously been observed in the 
rabbit (Cachero et al., 1996). It should be mentioned that Mir et al. (Mir et al., 1983), in their pioneer study, also 
found that 5% O2 administered in vivo did not significantly modify cAMP levels in the rat CB.  
The absence of significant changes in cAMP production in old animals is not incompatible with individual 
changes in adenylate cyclase activity, and/or metabotropic receptors but means that if individual changes 
occurred, the overall response is maintained.  
Effects of aging in cAMP accumulation in other preparations shows impairment of the activity of the catalytic 
subunit of adenylate cyclase in rats (Kilts et al., 2002), and in the heart of >60 year old humans (Brodde et al., 
1995). However, on the contrary, it has been described that the maximal ability of forskolin to increase cAMP in 
the adrenal medulla and liver is enhanced in 24 month old rats (Tumer et al., 1996). 
If a reduction in both A2-adenosine (positively coupled to adenylate cyclase) and D2-dopamine (negatively 
coupled to adenylate cyclase) receptor-mediated responses coexist at the CB, then compensatory effects in 
cAMP production can take place. Actually, the results obtained in the present work with exogenous adenosine 
and dopamine as well as manipulating their endogenous effects through antagonists showed that neither 
adenosine or dopamine receptors are significantly impaired in old animals. These effects of dopamine and 
adenosine were mediated through carotid body chemoreceptors, since these actions disappeared after bilateral 
section of the carotid sinus nerves. 
An additional interest to test the effects of dopamine and adenosine in the present model is their specific 
therapeutic indications in clinical practice: shock and supraventricular tachycardia, respectively. These clinical 
situations are associated with heart failure, more prevalent in the elderly, and the cardiorespiratory effects of 
exogenous dopamine and adenosine in aged humans or animals have never been investigated.  
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Dopamine has been shown to impair the ventilatory drive in response to hypoxemia and depresses minute 
ventilation and oxygen saturation in heart failure patients even when they are breathing room air (van de et al., 
1998). The present work provides evidence that these undesirable effect should be of the same magnitude in 
aged subjects.  
Domperidone, a D2-selective antagonist that do no cross the blood brain barrier (Baudry et al., 1979) 
administered alone increased basal VE as described in previous work (Gamboa et al., 2003;Lahiri et al., 1984) 
and we found statistically significant differences between 3 and 24 months old rats. This means that the 
inhibitory basal tonus of dopamine at the CB activity is less pronounced in old rats, probably resulting from a 
diminution of the receptor number throughout ageing. This is not an unexpected finding considering that it has 
been previously found that the density of striatal D2-receptors is significantly reduced in aged rats from 30 to 
80% depending on the study (Han et al., 1989;Marshall & Joyce, 1988;Petkov et al., 1988;Popoli et al., 1998). 
Anyway, at the CB this reduction is not enough to reduce the effect of exogenous dopamine which has the same 
magnitude in old rats and controls. 
The BP response triggered by dopamine, a short-lived rise followed to a return to baseline, occurred independent 
of the carotid sinus nerve afferentation and blockade of dopamine D2-receptors. This result warrants that the 
prompt hypertensive response evoked by dopamine challenge apparently occurs beyond the baroreceptor 
afferentation and may depend on D1-dopamine receptors at the heart and/or adrenoceptors. 
Adenosine, despite its dyspnoeic effect mediated by chemoreceptor activation (Burki et al., 2005), is a clinical 
useful tool to treat supraventricular tachycardia (Biaggioni et al., 1987;Riccardi et al., 2008), a common cardiac 
rhythm disturbance more frequently observed in the elderly (Medi et al., 2009). However, studies about this 
effect on aged subjects are missing. Although the present work was not focused in the crono/dromo and 
batmotropic effects of adenosine, an interesting finding is the less bradycardic effect observed during its 
exogenous application in aged animals, suggesting that the efficacy of adenosine to revert supraventricular 
tachycardia could be attenuated in the elderly. This could be attributed to a reduction in the density of adenosine 
receptors in the aged heart and may also involve an age-related reduction in the intrinsic ability of nodal tissue to 
respond to adenosine receptor activation (Hinschen et al., 2001). Some authors find an absence of changes in A1-
receptors density and G alpha protein levels but an adenosine A1-receptor function in rat ventricles to decrease 
with age and this was related to a reduction in the coupling between adenosine A1-receptor and their G proteins 
(Cai et al., 1997).  
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The excitatory effects of adenosine found in old rats suggest that the A2 -adenosine receptors at the carotid body 
are well preserved and that the chest discomfort caused by its exogenous administration will remain in the 
elderly. The excitatory effects obtained with low doses of SCH 58261 by itself, an adenosine A2A-antagonist that 
crosses the blood brain barrier  (El et al., 2000), are in agreement with the presence of A2A receptors with 
inhibitory effects on the control of breathing (Mayer et al., 2006) and  that central inhibitory control is 
apparently more relevant in basal conditions than the excitatory effects peripherally mediated. Therefore, low 
doses of A2A antagonists that cross BBB like SCH 58261 could be useful to treat central mediated ventilatory 
depressions without major actions in the cardiovascular system because the doses that antagonize the ventilatory 
effects did not modify BP and HR.  
In summary, we found that carotid body peripheral control of ventilation is not impaired with ageing. At the 
carotid body, endogenous dopaminergic inhibitory tonus is slightly reduced, however the decrease in ventilation 
caused by exogenous dopamine is preserved in aged animals, and should be taken in account in its use in critical 
care situations. The excitatory effect of exogenous adenosine mediated by A2A receptors at the carotid body 
chemosensors was not modified in ageing. In contrast, the bradycardic effect of exogenous adenosine mediated 
by A1 receptors is attenuated in old animals. These findings reduce the clinical interest of adenosine to revert 
supraventricular tachycardia in aged people. The maintained carotid body function throughout ageing confirms 
this organ as a valuable model of successful ageing.  
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FIGURE LEGENDS 
Figure 1. Age-dependent variation in body weight in rats. Data represent mean±S.E.M, n=30, ***p<0.0001, 
Mann-Whitney U-test, compared with 3 months old rats.  
Figure 2. Effect of ageing on basal values of respiratory  frequency (fR), tidal volume (VT), respiratory minute 
volume (VE), heart rate (HR) and arterial blood pressure (BP) in anesthetized and vagotomized rats (n=20). Data 
represent mean±S.E.M., *p<0.01; **p<0.001; ***p<0.0001, Mann-Whitney U-test vs  3 months old rats.  
Figure 3. Effects of common carotid occlusions (CCO) on respiratory airflow (PulmFI;ml/sec) respiratory rate 
(fR), tidal volume (VT or TV), respiratory minute volume (VE) and arterial blood pressure (BP) in anestethized 
and vagotomized rats throughout ageing (n=10). Original recordings obtained for CCO, during 10s (A) and 15s 
(B) in a 3 and a 24 months old rat. (C) Dose-response curves obtained in 6 animals: (□) 3 months old, (▲) 12 
months old and (■) 24 months old. 0 % effect corresponds to the values showed in Figure 2. Data represent 
mean±S.E.M..  
Figure 4. Effects of i.c. cumulative bolus injections of dopamine on respiratory airflow (PulmFI;ml/sec), 
respiratory rate (fR), tidal volume (VT), respiratory minute volume (VE), heart rate (HR) and arterial blood 
pressure (BP) in anestethized and vagotomized rats throughout ageing. Original recordings obtained for 
dopamine 30 nmol: (D) 3 months and (E) 24 months old rats. (A, B. C and F) dose-response curves obtained in 
20 animals: (□) 3 months old, (▲) 12 months old and (■) 24 months old. 0 % effect corresponds to the values 
showed in Figure 2. Data represent mean±S.E.M.. 
Figure 5. Dose-response curves for the effects of cumulative i.c. bolus injections of dopamine on respiratory 
minute volume (VE), heart rate (HR) and blood pressure (BP) in anestethized and vagotomized rats, in the 
absence and in the presence of i.v. infusion of domperidone. (A and D) 3 months old rats, (B) 12 months old rats 
and (C and E) 24 months old rats. (□) in the absence of domperidone (n=13-20); in the presence of  i.v. 
domperidone (n=6) (▼) 0.01 mg.Kg-1.min-1; (♦) 0.1 mg.Kg-1.min-1  and (●) 0.5 mg.Kg-1.min-1. 0% increase 
represents absolute values determined for the 12 s that preceded the injections. Data represent mean±S.E.M., 
*p<0.01; **p<0.001; ***p<0.0001, Mann-Whitney U-test compared with (□). 
Figure 6. Effect of domperidone i.v., by itself on respiratory minute volume (VE), heart rate (HR) and blood 
pressure (BP) in anestethized and vagotomized 3 and 24 months old rats (n=6). Only one dose was tested by 
animal. Data represent mean±S.E.M., *p<0,01, Mann-Whitney U-test comparing 3 vs 24 months old rats. 
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Figure 7. Effects of i.c. cumulative bolus injections of adenosine on respiratory airflow (PulmFI;ml/sec), 
respiratory rate (fR), tidal volume (VT), respiratory minute volume (VE), heart rate (HR) and arterial blood 
pressure (BP) in anestethized and vagotomized rats throughout ageing. Original recordings obtained for 
adenosine 30 nmol: (D) 3 months and (E) 24 months old rats. (A, B,C, F and G) dose-response curves obtained 
in: (□) 3 months old and (■) 24 months old (n=12). 0 % effect correspond to the values showed in Figure 2. Data 
represent mean±S.E.M., *p<0.01; ***p<0.0001, Mann-Whitney U-test compared with (□). 
Figure 8. Dose-response curves for the effects of cumulative i.c. bolus injections of adenosine on respiratory 
minute volume (VE), heart rate (HR) and blood pressure (BP) in anestethized and vagotomized rats, in the 
absence and in the presence of SCH 58261 i.v.. (A, C and E) 3 months old rats; (B, D and F) 24 months old rats. 
(□) in the absence of SCH 58261 (n=12); in the presence of  i.v. SCH 58261 (n=6) () 2 ng.Kg-1.min-1 and () 
20 ng.Kg-1.min-1. 0% increase represents absolute values determined for the 12 s that preceded the injections of 
adenosine. Data represent mean±S.E.M., *p<0.01; **p<0.001; ***p<0.0001, Mann-Whitney U-test compared 
with □. 
Figure 9. Effect of SCH 58261 alone (2 and 20 ng.Kg-1.min-1, i.v., 3 minutes infusion) on respiratory 
minute volume (VE), heart rate (HR) and arterial blood pressure (BP)  in anestethized and vagotomized rats. A. 3 
(□) and 24 (■) months old rats (n=6). Only one dose was tested by animal. Data represent mean±S.E.M., 
**p<0.001, Mann-Whitney U-test compared with vehicle and between the two doses of SCH 58261. Figure 10.  
(A) Effect of ageing on cAMP levels (expressed as pmol/CB and as pmol/mg tissue) in the CB of rats (n=12-16) 
incubated in normoxic conditions (20% O2). (B) Comparison between the levels of cAMP in the CBs of 3 
(n=14-18) and 24 (n=10-12) month old rats incubated with different oxygen concentrations. Data are 
mean±S.E.M.  
Figure 10.  (A) Effect of ageing on cAMP levels (expressed as pmol/CB and as pmol/mg tissue) in the CB of 
rats (n=12-16) incubated in normoxic conditions (20% O2). (B) Comparison between the levels of cAMP in the 
CBs of 3 (n=14-18) and 24 (n=10-12) month old rats incubated with different oxygen concentrations. Data are 
mean±S.E.M.  
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Supplement:  
In vivo Experiments 
Surgery and general procedures. The animals were anaesthetized 
by a single intraperitoneal injection of sodium pentobarbitone (60 
mg.Kg-1), supplemented intravenously with 10% of the initial dose as 
necessary, so as to make them areflexic to a nociceptive stimulus 
(effects of corneal reflexes and pinch to the front paw on the rise in 
arterial blood pressure (BP). They were placed supine, 
tracheostomized and breathing room air spontaneously. Bilateral 
midcervical vagotomy was also performed to abolish the role of 
afferents in the vagi innervating the lungs that had a major influence 
on respiratory activity (Marek et al., 2008).  
Systemic BP recordings and anaesthetic supplements were performed 
through the introduction of steriflex catheters (Vygon 160-07 and 
160-0) under a dissection microscope (Nikon SMZ-2B) in the right 
femoral artery and vein, respectively. All the catheters used in this 
experiments were filled with heparinised saline (100 IU.ml-1; heparin 
sodium). 
Body temperature was maintained close to 37±1°C using a heated 
underblanket governed by a rectal thermistor probe. 
The experiments lasted approximately 8:00 and upon completion of 
the studies, euthanasia of the rats was achieved by iv injection of a 
lethal dose of pentobarbital sodium (180 mg.Kg-1 iv), according to 
standard procedures.  
Bilateral common carotid occlusions (CCO). Both common 
carotid arteries were dissected approximately 1 cm below the 
bifurcation, and the bilateral arterial lumen was occluded by pulling 
simultaneously a surgical silk placed around each common carotid 
artery at this level, taking care to minimize stretching the carotid 
bifurcation. Three sequences of CCOs of 5, 10 and 15 s were 
performed with intervals of at least 5 min.  
Control values for respiratory frequency (fR), tidal volume (VT), BP 
and heart rate (HR) correspond to the mean value measured in a 
period of 25 s immediately before CCO. After CCO, the values of fR, 
VT, BP and HR were taken as the maximal effects measured during 
the period of 25 s that followed the CCOs, and were compared with 
controls. The maximal effects induced by CCOs always occurred in 
the first 25 s that followed the end of the CCO.  
For each experiment, in one rat, bilateral denervation of the CBs was 
performed by cutting the CSN. 
Drug administrations. Intravenous (iv) and intracarotid (ic) drug 
administrations were made, respectively, into the right femoral vein 
(Vygon 167.10+0.5-1.0mm) and into the right common carotid artery 
through a catheter (Vygon 167.07+0.3-0.7mm) introduced  through 
the external carotid artery with its tip positioned just below the 
bifurcation. Infusions rate and duration were 0.5 mL.min-1 during 3 
min (Braun perfusion pump) and bolus injections  made in a volume 
of 0.1 mL, washed in with 0.2 mL of 0.9% aqueous sodium chloride. 
Cardioventilatory parameters. Recordings of pulmonary air flow 
(PulmFI;ml/sec) was obtained by a HSE-pneumotachometer PTM 
type, a differential pressure transducer (model DP 45-14 Validyne 
Engineering, NorthNorthridge, CA) and a pressure amplifier (Plugsys 
Housings, model 603, HSE-HA GmgH). BP was measured with a 
pressure transducer (model Isotec, HSE-HA GmgH) and a pressure 
amplifier (Plugsys Housings, model 603, HSE-HA GmgH). VT and HR 
were calculated by the software HSE-Harvard Pulmodyn W, 
respectively from PulmFI and BP. A rectal oximetry sensor (SurgiVet 
V90004 Capnograph) provided a continuous monitoring of PO2.  
Cardioventilatory data acquisition (PulmFI, VT, fR, BP, HR) were 
obtained continuously during the experiments using the software 
HSE-Harvard Pulmodyn W. Respiratory minute volume (VE), defined 
as the product of VT and fR, was further calculated. VT and VE were 
normalized for body weight (mL.Kg-1 and mL.min-1.Kg-1, 
respectively). 
Experimental protocols with drug administrations. Three 
cumulative dose-response curves for adenosine or dopamine were 
performed in each rat: ic bolus after 3 minute infusion of drug 
vehicles, 0.9% aqueous sodium chloride (in the experiments with 
domperidone) or DMSO (in the experiments with SCH 58261). Two 
cumulative dose-response curves for adenosine or dopamine were 
performed in each rat: i.c. bolus after 3 minute infusion of the 
antagonist, domperidone (in the experiments with dopamine) or SCH 
58261 (in the experiments with adenosine). Only one dose of the D2 
and A2A antagonists (domperidone or SCH 58261) was tested per 
animal. The intervals between drug injections or infusions were at 
least of 5 min. Control values for fR, VT, BP and HR correspond to the 
mean value measured in a period of 25 s immediately before drug 
administration. After drug ic administration, the values of fR, VT, BP 
and HR were taken as the maximal effects measured during the 
period of 25 s that followed the injections, and were compared with 
controls. The maximal effects induced by ic injections of dopamine or 
adenosine always occurred in the first 25 s that followed the end of 
the injections.  
For each experiment, in one rat, bilateral denervation of the carotid 
bodies was performed by cutting the CSN. 
 
 
In vitro Experiments 
Surgery. CBs were removed from the carotid bifurcation of 
anaesthetized rats with sodium pentobarbitone (60 mg.Kg-1), 
tracheostomized and breathing spontaneously with the aid of a Nikon 
SMZ-2B dissection scope. After removal of the CBs, the animals were 
killed by an intracardiac injection of a lethal dose of pentobarbital.  
Experimental protocols with cAMP. Immediately after surgical 
removal, the CBs were pre-incubated for 15 min at 37 ºC in a shaker 
bath in medium equilibrated with 95% O2 / 5% CO2 to allow the 
recovery of the preparation. Incubation medium was a modified Krebs 
solution  composed of: NaCl 116 mM; NaHCO3 24 mM; KCl 5 mM; 
CaCl2 2 mM; MgCl2 1.1 mM; HEPES 10 mM; glucose 5.5 mM; pH 
7.42. After the pre-incubation period, the CBs were placed in 2 mL 
Eppendorf tubes containing 1 mL of fresh incubating solution of 
identical composition and containing, in most of the experiments, 
500 M isobutylmethylxanthine (IBMX), a phosphodiesterase 
inhibitor. The incubating solutions were equilibrated with 
95 %O2/5 %CO2 (hyperoxia), 20 %O2/5 %CO2/75 %N2 (normoxia), 
10 %O2/5 %CO2/85 %N2 (mild hypoxia) or 5 %O2/5 %CO2/90 %N2 
(moderately intense hypoxia); incubation lasted 30 min and was also 
carried out in the metabolic bath at 37oC. During the entire 
incubation period the solutions were gently bubbled with the selected 
gas mixture saturated with water vapor via a fine plastic tube 
penetrating the tubes through the caps. Extraction of cyclic 
nucleotides and cAMP quantification were performed as previously 
described by Batuca et al.. In brief, to extract cyclic nucleotides from 
the CBs, they were immersed in cold 6% (w/v) trichloroacetic acid 
(600µL) for 10 min, homogenised using a Potter homogeniser with a 
glass and further centrifuged at 12000 g for 10 min (4 ºC). The 
supernatants were washed four times in 3 mL of water-saturated 
diethyl ether solution, the remaining aqueous phase was lyophilised, 
and the sealed samples were stored at -20 ºC until cAMP was 
assayed using an EIA commercial kit (GE Healthcare Bio-Sciences AB, 
Sweden) (Batuca et al., 2003) . 
Drugs  
All drugs were prepared on the day of each experiment. Doses of all 
drugs were calculated on the basis of salt weight. Dopamine, 
adenosine and domperidone were prepared in saline (0.9% NaCl). 
Stock solutions (5mM) of SCH 58261 was prepared in 
dimethylsulfoxide (DMSO) and stored at –20ºC until use. Stock 
solution was further diluted with saline prior to each experiment. The 
highest concentration of the vehicle in venous perfusion was 0.4 mM 
or 0.01%.  
 
 
